Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioenergy Life Science (BLS) is a biotechnology company specializing in the development of functional ingredients that enhance cellular energy and metabolic health. The company is globally recognized for its flagship product, Bioenergy Ribose, a patented and FDA-affirmed GRAS D-ribose ingredient that supports adenosine triphosphate (ATP) synthesis for heart health and sports performance. Beyond ribose, BLS develops innovative metabolic solutions such as RiaGev, which combines ribose and nicotinamide to boost NAD+ levels and support healthy aging. Headquartered in Minnesota, the company operates as a subsidiary of Chengzhi Life Science, utilizing advanced fermentation technologies for large-scale ingredient production. Their products are widely integrated into dietary supplements, functional foods, and beverages by leading health brands worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioenergy Ribose.